Preparation and optimization of rivastigmine-loaded tocopherol succinate-based solid lipid nanoparticles

References

• Alzheimer’s, A., 2015. 2015 Alzheimer's disease facts and figures. Alzheimer's and Dementia: The Journal of the Alzheimer's Association, 11 (3), 332.
   PubMed Web of Science ®Google Scholar
• Awad, T.S., et al., 2008. Effect of cooling and heating rates on polymorphic transformations and gelation of tripalmitin solid lipid nanoparticle (SLN) suspensions. Food Biophysics, 3 (2), 155–162.
   Web of Science ®Google Scholar
• Baig, M.S., et al., 2016. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: optimization, in vitro release, ocular tolerance, and antibacterial activity. International Journal of Biological Macromolecules, 85, 258–270.
   PubMed Web of Science ®Google Scholar
• Blasi, P., et al., 2007. Solid lipid nanoparticles for targeted brain drug delivery. Advanced Drug Delivery Reviews, 59 (6), 454–477.
   PubMed Web of Science ®Google Scholar
• Dysken, M.W., et al., 2014. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA, 311 (1), 33–44.
   PubMed Web of Science ®Google Scholar
• Eskandani, M., and Nazemiyeh, H., 2014. Self-reporter shikonin-act-loaded solid lipid nanoparticle: Formulation, physicochemical characterization and geno/cytotoxicity evaluation. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 59, 49–57.
   PubMed Web of Science ®Google Scholar
• Gasco, M.R., 1993. Method for producing solid lipid microspheres having a narrow size distribution. Google Patents.
   Google Scholar
• Gastaldi, L., et al., 2014. Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 87 (3), 433–444.
   PubMed Web of Science ®Google Scholar
• Ghadiri, M., et al., 2012. Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modeling of entrapment efficiency and particle size. International Journal of Pharmaceutics, 424 (1–2), 128–137.
   PubMed Web of Science ®Google Scholar
• Hao, J., et al., 2011. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. International Journal of Nanomedicine, 6, 683–692.
   PubMed Web of Science ®Google Scholar
• Hao, J., et al., 2012. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. European Journal of Pharmaceutical Science, 47 (2), 497–505.
   PubMed Web of Science ®Google Scholar
• Helgason, T., et al., 2008. Influence of polymorphic transformations on gelation of tripalmitin solid lipid nanoparticle suspensions. Journal of the American Oil Chemists' Society, 85 (6), 501–511.
   Web of Science ®Google Scholar
• Helgason, T., et al., 2009. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). Journal of Colloid and Interface Science, 334 (1), 75–81.
   PubMed Web of Science ®Google Scholar
• Jose, S., et al., 2014. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. International Journal of Pharmaceutics, 474 (1–2), 6–13.
   PubMed Web of Science ®Google Scholar
• Kaur, I.P., et al., 2008. Potential of solid lipid nanoparticles in brain targeting. Journal of Controlled Release, 127 (2), 97–109.
   PubMed Web of Science ®Google Scholar
• Lakshmi, P.D., Nair, R., C, M., et al., 2012. Solid lipid nanoparticle systems for delivery of drugs to the brain. International Journal of Biopharmaceutics, 3, 70–77.
   Google Scholar
• Lavon, O., et al., 2015. Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers. Neurotoxicology, 49, 36–44.
   PubMed Web of Science ®Google Scholar
• Morris, M.C., et al., 2015. Brain tocopherols related to Alzheimer's disease neuropathology in humans. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 11 (1), 32–39.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., et al., 1997. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharmaceutical Research, 14 (4), 458–462.
   PubMed Web of Science ®Google Scholar
• Nabi-Meibodi, M., et al., 2013. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method. Colloids and Surfaces. B, Biointerfaces, 112, 408–414.
   PubMed Web of Science ®Google Scholar
• Nasrollahzadeh, M., et al., 2016. Development and optimization of cephalexin-loaded solid lipid nanoparticles using D-optimal design. Advanced Science, Engineering and Medicine, 8 (9), 695–704.
   Google Scholar
• Neves, A.R., et al., 2015. Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E. Nanotechnology, 26 (49), 495103.
   PubMed Web of Science ®Google Scholar
• Rao, B.M., et al., 2005. A stability indicating LC method for rivastigmine hydrogen tartrate. Journal of Pharmaceutical and Biomedical Analysis, 37 (1), 57–63.
   PubMed Web of Science ®Google Scholar
• Schwarz, J., and Weisspapir, M., 2005. Colloidal solid lipid vehicle for pharmaceutical use. Google Patents.
   Google Scholar
• Shah, B., et al., 2015. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 78, 54–66.
   PubMed Web of Science ®Google Scholar
• Shah, R.M., et al., 2014. Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique. Journal of Colloid and Interface Science, 428, 286–294.
   PubMed Web of Science ®Google Scholar
• Sharmila, S., 2013. Development and validation of UV-spectrophotometric method for the estimation of rivastigmine tartrate in bulk and pharmaceutical dosage form. Indo American Journal of Pharmaceutical Research, 3 (10), 8394–8399.
   Google Scholar
• Silva, A., et al., 2011. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids and Surfaces. B, Biointerfaces, 86 (1), 158–165.
   PubMed Web of Science ®Google Scholar
• Srikanth, M., and Kessler, J.A., 2012. Nanotechnology-novel therapeutics for CNS disorders. Nature Reviews. Neurology, 8 (6), 307–318.
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai, W., Tungpradit, W., and Plianbangchang, P., 2007. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. International Journal of Pharmaceutics, 337 (1), 299–306.
   PubMed Web of Science ®Google Scholar
• Venkateswarlu, V., and Manjunath, K., 2004. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. Journal of Controlled Release: Official Journal of the Controlled Release Society, 95 (3), 627–638.
   PubMed Web of Science ®Google Scholar
• Wohlfart, S., Gelperina, S., and Kreuter, J., 2012. Transport of drugs across the blood-brain barrier by nanoparticles. Journal of Controlled Release: Official Journal of the Controlled Release Society, 161 (2), 264–273.
   PubMed Web of Science ®Google Scholar
• Yang, Z.Z., et al., 2013. Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration. International Journal of Pharmaceutics, 452 (1), 344–354.
   PubMed Web of Science ®Google Scholar
• Zhang, C., et al., 2013. Preparation and optimization of triptolide-loaded solid lipid nanoparticles for oral delivery with reduced gastric irritation. Molecules (Basel, Switzerland), 18 (11), 13340–13356.
   PubMed Web of Science ®Google Scholar